# 2026-15075: FDA Greenlights Noise-Canceling Baby Incubators as Class II

2026-15075, Medical Devices; General Hospital and Personal Use Devices; Classification of the Active Noise Attenuation System for Infant Incubators, is a Federal Register rule from Health and Human Services Department, Food and Drug Administration published 2026-07-27, effective 2026-07-27; PRIA reads it as touching household money (as of 2026-08-03).

- Canonical: https://policyrisk.com/federal-register/2026-15075
- As of: 2026-08-03
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-15075
- Title: Medical Devices; General Hospital and Personal Use Devices; Classification of the Active Noise Attenuation System for Infant Incubators
- Type: Rule
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 46835
- Published: 2026-07-27
- Effective: 2026-07-27
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-08-03

## In one line

FDA Greenlights Noise-Canceling Baby Incubators as Class II

## Summary

The Food and Drug Administration (FDA) is classifying the active noise attenuation system for infant incubators into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the active noise attenuation system for infant incubators. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

## Effects PRIA read

- Reclassification Lowers Approval Burden: benefit, medium. The FDA has classified active noise attenuation systems for infant incubators as Class II with special controls (codified at 21 CFR 880.5405). Because of the De Novo classification, this device type can serve as a predicate for future devices, letting other makers use the less-burdensome 510(k) pat…
- Device Remains Subject to 510(k) Notification: cost, medium. FDA states that active noise attenuation systems for infant incubators are subject to premarket notification under section 510(k) of the FD&C Act and have not been exempted under section 510(m). Manufacturers must submit a 510(k) to reasonably assure safety and effectiveness unless FDA later exempt…
- Mandatory Testing, Software, and Labeling Rules: cost, medium. FDA's special controls (21 CFR 880.5405) require manufacturers to perform non-clinical performance testing including verification/validation of acoustic parameters and attenuation performance, software validation and hazard analysis, electrical safety and electromagnetic compatibility testing, bioc…
- Classification Aims to Improve Patient Access: benefit, low. FDA says classifying this device as Class II will provide reasonable assurance of safety and effectiveness and will enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens. This change became effective July 27, 2026, and the classification was applicable on…

## Related documents

- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27
- [2026-20727](https://policyrisk.com/federal-register/2026-20727): Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorgani…, 2026-10-09

## Sources
- [2026-15075 on federalregister.gov](https://www.federalregister.gov/documents/2026/07/27/2026-15075/medical-devices-general-hospital-and-personal-use-devices-classification-of-the-active-noise)
- [2026-15075 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-07-27/pdf/2026-15075.pdf)

## Related
- [Previous: 2026-15074, Medical Devices; Gastroenterology-Urology Devices; Classification of the Non-Me…](https://policyrisk.com/federal-register/2026-15074)
- [Next: 2026-15093, Pacific Halibut Fisheries of the West Coast; 2026 Catch Sharing Plan; Inseason…](https://policyrisk.com/federal-register/2026-15093)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-15075 (as of 2026-08-03).